Evidence map›Paper›PMID 37943314›Full record

ArticleEuropean radiology2024

The impact of FAP imaging in lung cancer and beyond: a new chapter.

Emil Novruzov, Yuriko Mori, Abass Alavi, Frederik L Giesel

Open access · hybridAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Targeting of fibroblast activation protein with [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Review
  3. Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Efficient α and βEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Emil NovruzovDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, 40225, Düsseldorf, Germany, Moorenstrasse 5. Emil.Novruzov@med.uni-duesseldorf.de.ORCID http://orcid.org/0000-0003-1914-1332
Yuriko MoriDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, 40225, Düsseldorf, Germany, Moorenstrasse 5.
Abass AlaviDivision of Nuclear Medicine, Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA, 19104, USA.
Frederik L GieselDepartment of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, 40225, Düsseldorf, Germany, Moorenstrasse 5.
Düsseldorf University Hospital · DEHospital of the University of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Heterocyclic Compounds, 1-RingLung NeoplasmsQuinolinesDiagnosis, DifferentialFluorodeoxyglucose F18HumansLungPositron-Emission TomographyPositron Emission Tomography Computed Tomography1,4,7-triazacyclononane-N,N',N''-triacetic acid68Ga-FAPIFluorodeoxyglucose F18Heterocyclic Compounds, 1-RingQuinolines

Identifiers

PMID37943314
PMCPMC10873428
OpenAlexW4388523656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.